[HTML][HTML] PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway

D Tang, J Zhang, Z Yuan, H Zhang, Y Chong… - Oncotarget, 2017 - ncbi.nlm.nih.gov
D Tang, J Zhang, Z Yuan, H Zhang, Y Chong, Y Huang, J Wang, Q Xiong, S Wang, Q Wu…
Oncotarget, 2017ncbi.nlm.nih.gov
Galectin-1 has previously been shown to be strongly expressed in activated pancreatic
stellate cells (PSCs) and promote the development and metastasis of pancreatic ductal
adenocarcinoma (PDAC). However, the molecular mechanisms by which Galectin-1
promotes the malignant behavior of pancreatic cancer cells remain unclear. In this study, we
examined the effects of Galectin-1 knockdown or overexpression in PSCs co-cultured with
pancreatic cancer (PANC-1) cells. Immunohistochemical analysis showed expression of …
Abstract
Galectin-1 has previously been shown to be strongly expressed in activated pancreatic stellate cells (PSCs) and promote the development and metastasis of pancreatic ductal adenocarcinoma (PDAC). However, the molecular mechanisms by which Galectin-1 promotes the malignant behavior of pancreatic cancer cells remain unclear. In this study, we examined the effects of Galectin-1 knockdown or overexpression in PSCs co-cultured with pancreatic cancer (PANC-1) cells. Immunohistochemical analysis showed expression of epithelial-mesenchymal transition (EMT) markers and MMP9 were positively associated with the expression of Galectin-1 in 66 human PDAC tissues. In addition, our in vitro studies showed PSC-derived Galectin-1 promoted the proliferation, invasion, and survival (anti-apoptotic effects) of PANC-1 cells. We also showed PSC-derived Galectin-1 induced EMT of PANC-1 cells and activated the NF-кB pathway in vitro. Our mixed (PSCs and PANC-1 cells) mouse orthotopic xenograft model indicated that overexpression of Galectin-1 in PSCs significantly promoted the proliferation, growth, invasion, and liver metastasis of the transplanted tumor. Moreover, Galectin-1 overexpression in PSCs was strongly associated with increased expression of EMT markers in both the orthotopic xenograft tumor in the pancreas and in metastatic lesions of naked mice. We conclude that PSC-derived Galectin-1 promotes the malignant behavior of PDAC by inducing EMT via activation of the NF-κB pathway. Our results suggest that targeting Galectin-1 in PSCs could represent a promising therapeutic strategy for PDAC progression and metastasis.
ncbi.nlm.nih.gov